Title : Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.

Pub. Date : 2016 Jun

PMID : 27055778

1 Functional Relationships(s)
Compound Name
Protein Name
1 Fingolimod therapy increased the ratio of naive to memory cells, elevated the percentage of plasma cells and highly increased the proportion of transitional B cells as well as additional regulatory subsets, including: IL10(+), CD25(+) and CD5(+) B cells. Fingolimod Hydrochloride interleukin 2 receptor subunit alpha Homo sapiens